Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) Equity-to-Asset : 0.51 (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Macro Group Pharmaceuticals (Macro Capital) Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Macro Group Pharmaceuticals (Macro Capital) Co's Total Stockholders Equity for the quarter that ended in Sep. 2023 was E£465.0 Mil. Macro Group Pharmaceuticals (Macro Capital) Co's Total Assets for the quarter that ended in Sep. 2023 was E£913.2 Mil. Therefore, Macro Group Pharmaceuticals (Macro Capital) Co's Equity to Asset Ratio for the quarter that ended in Sep. 2023 was 0.51.

The historical rank and industry rank for Macro Group Pharmaceuticals (Macro Capital) Co's Equity-to-Asset or its related term are showing as below:

CAI:MCRO' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.51 Med: 0.56 Max: 0.64
Current: 0.51

During the past 3 years, the highest Equity to Asset Ratio of Macro Group Pharmaceuticals (Macro Capital) Co was 0.64. The lowest was 0.51. And the median was 0.56.

CAI:MCRO's Equity-to-Asset is ranked worse than
53.9% of 1935 companies
in the Consumer Packaged Goods industry
Industry Median: 0.54 vs CAI:MCRO: 0.51

Macro Group Pharmaceuticals (Macro Capital) Co Equity-to-Asset Historical Data

The historical data trend for Macro Group Pharmaceuticals (Macro Capital) Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Macro Group Pharmaceuticals (Macro Capital) Co Equity-to-Asset Chart

Macro Group Pharmaceuticals (Macro Capital) Co Annual Data

Trend

Dec20

Dec21

Dec22

Equity-to-Asset

0.62

0.55

Macro Group Pharmaceuticals (Macro Capital) Co Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Sep23
Equity-to-Asset	Get a 7-Day Free Trial						0.52	0.56	0.56	0.55	0.51

Competitive Comparison of Macro Group Pharmaceuticals (Macro Capital) Co's Equity-to-Asset

For the Household & Personal Products subindustry, Macro Group Pharmaceuticals (Macro Capital) Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Macro Group Pharmaceuticals (Macro Capital) Co's Equity-to-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Macro Group Pharmaceuticals (Macro Capital) Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Macro Group Pharmaceuticals (Macro Capital) Co's Equity-to-Asset falls into.

Macro Group Pharmaceuticals (Macro Capital) Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Macro Group Pharmaceuticals (Macro Capital) Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )	=	Total Stockholders Equity	/	Total Assets
	=	462.833	/	849.635
	=	0.54

Macro Group Pharmaceuticals (Macro Capital) Co's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	464.953	/	913.227
	=	0.51

Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Macro Group Pharmaceuticals (Macro Capital) Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Macro Group Pharmaceuticals (Macro Capital) Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

83, Al Moltaka Al Arabi, Sheraton, Cairo, EGY

Website

https://www.macro-egy.com

Macro Group Pharmaceuticals (Macro Capital) Co is principally engaged in the manufacture and sale of cosmeceutical and ventured into nutraceutical products.